Study of immune cells in inactive JIA
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at specific white blood cells (lymphocytes) in people with juvenile idiopathic arthritis (JIA) whose disease is inactive. It aims to understand how these cells differ based on the type of JIA and the medications used.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years old or older.
- You must have been diagnosed with juvenile idiopathic arthritis (JIA) by a doctor.
- You must be taking DMARDs (disease-modifying antirheumatic drugs) for your JIA.
- Your JIA must be inactive (not currently causing symptoms).
- You cannot have any other autoimmune disease besides JIA.
- You cannot have a low lymphocyte count that you were born with or developed later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood markers relate to disease activity in children with juvenile idiopathic arthritis (JIA). It aims to help doctors better understand and track the condition, which could lead to improved care.
This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study creates a personalized medicine network to better understand and treat childhood arthritis. If you have JIA or unexplained joint inflammation, researchers will look at your biology to find the best treatment approach for you.
This study looks at blood (and related) markers that may reflect inflammation in people with juvenile idiopathic arthritis. It may help doctors better understand disease activity and guide future care for patients who are able to join.
This study follows people with systemic juvenile idiopathic arthritis (sJIA), adult-onset Still’s disease (AOSD), and similar conditions to learn how the illness works over time. It also collects blood and family information to study genetics and explain what causes flare-ups, which may help future care.
Hear when a new Juvenile Idiopathic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.